SPAYVAC FOR WILDLIFE, INC. ANNOUNCES COMPLETION OF SPAYVAC RESEARCH AND PRODUCTION FACILITY IN MADISON, WISCONSIN

PR Newswire08/19 20:00

Stocks in Play: BioVaxys Technology Corp.

Baystreet.ca07/12 21:42

CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)

newsfile05/16 22:21

Press Release: BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER

Dow Jones04/30 20:00

BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY

PR Newswire04/10 20:00

BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE

PR Newswire04/03 20:02